TrivarX Limited has appointed Dr Danielle Meyrick as Chief Executive Officer effective 1 June 2026. This appointment is part of the company's strategy to enhance its clinical and regulatory leadership as it progresses its Stabl-Im stable isotope-enhanced MRI platform.
Who to call at TrivarX, and when
A new leader at TrivarX brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day TrivarX raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at TrivarX, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
TrivarX
Location
Australia
About
TrivarX is focused on developing advanced diagnostic technologies in the healthcare sector. The company aims to improve the accuracy and effectiveness of medical diagnostics. Its innovations target high-growth markets within neurology and oncology. The acquisition of Stabl-Im aligns with its strategic goals.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TrivarX changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
AustraliaBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics